Work

Trends and disparities in type 1 diabetes–related mortality in the United States, 1999–2023

Year: 2026

Type: article

Abstract: Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by pancreatic β-cell destruction and lifelong insulin dependence. 1 Although therapeutic advances-including insulin analogs and continuous glucose monitoring (CGM)-have improved glycaemic management, individuals with T1DM continue to face elevated risks of acute metabolic crises and long-term complications.2,3 Given these persistent challenges, this study examines trends in T1DM-related mortality among U.S. adults from 1999 to 2023 to inform equitable prevention and management strategies.

Source: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.70546

Authors: Kaixin Yao, Xichen Yang, Shuhui Lei, Shuwen Yin, Zhongyan Xu

Institutions: Shanxi Medical University, Bethune International Peace Hospital, Second Hospital of Shanxi Medical University

Language: English

Topic: Diabetes Management and Research

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Centers for Disease Control and Prevention